• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时测定四种质子泵抑制剂——兰索拉唑、奥美拉唑、泮托拉唑和雷贝拉唑:一种新型通用高效液相色谱-紫外检测法的建立及其在临床药代动力学研究中的应用

Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.

作者信息

Bharathi D Vijaya, Hotha Kishore Kumar, Jagadeesh B, Chatki Pankaj K, Thriveni K, Mullangi Ramesh, Naidu A

机构信息

Bioanalytical Department, Integrated Product Development, Dr Reddy's Laboratories Ltd, Bachupalli, Hyderabad-500 072, India.

出版信息

Biomed Chromatogr. 2009 Jul;23(7):732-9. doi: 10.1002/bmc.1177.

DOI:10.1002/bmc.1177
PMID:19360758
Abstract

A highly selective, sensitive and accurate HPLC method has been developed and validated for the estimation of four proton-pump inhibitors (PPI), lansoprazole (LPZ), omeprazole (OPZ), pantoprazole (PPZ) and rabeprazole (RPZ), with 500 microL human plasma using zonisamide as an internal standard (IS). The sample preparation involved simple liquid-liquid extraction of LPZ, OPZ, PPZ and RPZ and IS from human plasma with ethyl acetate. The baseline separation of all the peaks was achieved with 0.1% triethylamine (pH 6.0):acetonitrile (72:28, v/v) at a flow rate of 1 mL/min on a Zorbax C(8) column. The total chromatographic run time was 11.0 min and the simultaneous elution of IS, OPZ, RPZ, PPZ and LPZ occurred at approximately 2.42, 4.45, 5.02 and 9.37 min, respectively. The method was proved to be accurate and precise at linearity range of 20.61-1999.79 ng/mL with a correlation coefficient (r) of >or=0.999. The limit of quantitation for each of the PPI studied was 20.61 ng/mL. The intra- and inter-day precision and accuracy values were found to be within the assay variability limits as per the FDA guidelines. The developed assay method was applied to a pharmacokinetic study in human volunteers.

摘要

已开发并验证了一种高选择性、灵敏且准确的高效液相色谱法,用于测定四种质子泵抑制剂(PPI),即兰索拉唑(LPZ)、奥美拉唑(OPZ)、泮托拉唑(PPZ)和雷贝拉唑(RPZ),以内标(IS)唑尼沙胺为内标,使用500微升人血浆。样品制备包括用乙酸乙酯从人血浆中简单液液萃取LPZ、OPZ、PPZ、RPZ和IS。在Zorbax C(8)柱上,以0.1%三乙胺(pH 6.0):乙腈(72:28,v/v)为流动相,流速为1 mL/min,实现了所有峰的基线分离。总色谱运行时间为11.0分钟,IS、OPZ、RPZ、PPZ和LPZ的同时洗脱分别出现在约2.42、4.45、5.02和9.37分钟。该方法在20.61 - 1999.79 ng/mL的线性范围内被证明准确且精密,相关系数(r)≥0.999。所研究的每种PPI的定量限为20.61 ng/mL。根据FDA指南,日内和日间精密度及准确度值均在分析变异性限度内。所开发的分析方法应用于人体志愿者的药代动力学研究。

相似文献

1
Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.同时测定四种质子泵抑制剂——兰索拉唑、奥美拉唑、泮托拉唑和雷贝拉唑:一种新型通用高效液相色谱-紫外检测法的建立及其在临床药代动力学研究中的应用
Biomed Chromatogr. 2009 Jul;23(7):732-9. doi: 10.1002/bmc.1177.
2
Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.改进的 HPLC 法测定人血浆中的四种 PPIs,奥美拉唑、泮托拉唑、兰索拉唑和雷贝拉唑。
J Pharm Pharm Sci. 2010;13(1):1-10. doi: 10.18433/j3gp4q.
3
Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.通过固相萃取-液相色谱法同时测定血浆中兰索拉唑对映体及其代谢产物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 May 25;804(2):389-95. doi: 10.1016/j.jchromb.2004.01.057.
4
Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.液相色谱-电喷雾电离串联质谱法测定人血浆中奥美拉唑的高灵敏度方法:在临床药代动力学研究中的应用
Biomed Chromatogr. 2009 Apr;23(4):390-6. doi: 10.1002/bmc.1129.
5
High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction.采用固相萃取法测定人血浆中雷贝拉唑含量的高效液相色谱法
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):209-14. doi: 10.1016/j.jchromb.2004.11.032.
6
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.同时定量分析 6 种质子泵抑制剂和单一标记物,并评估研究药物在用于连续输注的聚丙烯注射器中的稳定性。
Drug Des Devel Ther. 2020 Dec 24;14:5689-5698. doi: 10.2147/DDDT.S279302. eCollection 2020.
7
Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study.以左氧氟沙星为内标同时定量测定人血浆中加替沙星、司帕沙星和莫西沙星的高效液相色谱法的建立与验证:临床药代动力学研究中的应用
Biomed Chromatogr. 2008 Nov;22(11):1288-95. doi: 10.1002/bmc.1060.
8
Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study.生物等效性研究中雷贝拉唑测定的直接进样、柱切换液相色谱技术
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):247-54. doi: 10.1016/j.jchromb.2004.09.053.
9
High-performance liquid chromatography method for the quantification of pantoprazole in human plasma.用于定量测定人血浆中泮托拉唑的高效液相色谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5;822(1-2):326-9. doi: 10.1016/j.jchromb.2005.06.011.
10
Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.采用柱切换高效液相色谱法测定人血浆中雷贝拉唑及其活性代谢产物雷贝拉唑硫醚,并将其应用于药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):238-43. doi: 10.1016/j.jchromb.2005.07.027.

引用本文的文献

1
Greenness-sustainability metrics for assessment smart-chemometric spectrophotometric strategy for evaluation of the combination of six gastric proton-pump inhibitors with two selected impurities.用于评估六种胃质子泵抑制剂与两种选定杂质组合的智能化学计量分光光度法策略的绿色度-可持续性指标
MethodsX. 2024 Mar 28;12:102670. doi: 10.1016/j.mex.2024.102670. eCollection 2024 Jun.
2
Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.质子泵抑制剂剂型的研发:现状、挑战与未来展望
Pharmaceutics. 2022 Sep 25;14(10):2043. doi: 10.3390/pharmaceutics14102043.
3
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.
同时定量分析 6 种质子泵抑制剂和单一标记物,并评估研究药物在用于连续输注的聚丙烯注射器中的稳定性。
Drug Des Devel Ther. 2020 Dec 24;14:5689-5698. doi: 10.2147/DDDT.S279302. eCollection 2020.
4
A New Solid-Phase Extraction Method for Determination of Pantoprazole in Human Plasma Using High-Performance Liquid Chromatography.一种使用高效液相色谱法测定人血浆中泮托拉唑的新型固相萃取方法
Open Access Maced J Med Sci. 2019 Jun 15;7(11):1757-1761. doi: 10.3889/oamjms.2019.237.
5
Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.雷贝拉唑钠缓释胶囊在酸性介质中溶出度测试的开发与验证
Drug Dev Ind Pharm. 2016 Oct;42(10):1669-77. doi: 10.3109/03639045.2016.1161644. Epub 2016 Apr 11.
6
Development and validation of a UPLC method for rapid and simultaneous analysis of proton pump inhibitors.一种用于快速同时分析质子泵抑制剂的超高效液相色谱法的开发与验证
AAPS PharmSciTech. 2015 Feb;16(1):30-4. doi: 10.1208/s12249-014-0207-7. Epub 2014 Aug 27.
7
Manipulating ratio spectra for the spectrophotometric analysis of diclofenac sodium and pantoprazole sodium in laboratory mixtures and tablet formulation.在实验室混合物和片剂制剂中对双氯芬酸钠和泮托拉唑钠进行分光光度分析时对比率光谱的操控。
ScientificWorldJournal. 2014 Feb 18;2014:495739. doi: 10.1155/2014/495739. eCollection 2014.
8
Complexity in estimation of esomeprazole and its related impurities' stability in various stress conditions in low-dose aspirin and esomeprazole magnesium capsules.低剂量阿司匹林和埃索美拉唑镁胶囊中埃索美拉唑及其相关杂质在各种应激条件下稳定性评估的复杂性。
Sci Pharm. 2013 Apr-Jun;81(2):475-92. doi: 10.3797/scipharm.1212-13. Epub 2013 Feb 18.